Carregant...

Binding of clinical inhibitors to a model precursor of a rationally selected multidrug resistant HIV-1 protease is significantly weaker than to the released mature enzyme

We have systematically validated the activity and inhibition of a HIV-1 protease (PR) variant bearing 17 mutations (PR(S17)), selected to represent high resistance by machine learning on genotype-phenotype data. Three of five mutations in PR(S17) correlating with major drug resistance, M46L, G48V an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochemistry
Autors principals: Park, Joon H., Sayer, Jane M., Aniana, Annie, Yu, Xiaxia, Weber, Irene T., Harrison, Robert W., Louis, John M.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013724/
https://ncbi.nlm.nih.gov/pubmed/27039930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.biochem.6b00012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!